EVALUATION OF A HETEROLOGOUS PRIME-BOOST VACCINE SCHEDULE BASED ON LOW SEROPREVALENT ADENOVIRUS VECTORS FOR MALARIA

被引：0
|
作者：
Rodriguez, Ariane Rodriguez [1 ]
Gillissen, Gert [1 ]
Tax, Dennis [1 ]
Mintardjo, Ratna [1 ]
Kuipers, Harmjan [1 ]
Custers, Jerome [1 ]
Pau, Maria Grazia [1 ]
Kostense, Stefan [1 ]
Hendriks, Jenny [1 ]
ter Haak, Mariska [1 ]
Goudsmit, Jaap [1 ]
Radosevic, Katarina [1 ]
机构：
[1] Crucell, Leiden, Netherlands
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2009年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1033
引用
收藏
页码：297 / 298
页数：2
相关论文
共 50 条
  • [21] Treatment of Cancer by Adenovirus Based Prime-Boost Regimes
    Steffensen, Maria Abildgaard
    Holst, Peter J.
    Sorensen, Maria R.
    Christensen, Jan P.
    Thomsen, Allan R.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (06) : 529 - 529
  • [22] Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys
    Liu, Jinyan
    Ewald, Bonnie A.
    Lynch, Diana M.
    Denholtz, Matthew
    Abbink, Peter
    Lemckert, Angelique A. C.
    Carville, Angela
    Mansfield, Keith G.
    Havenga, Menzo J.
    Goudsmit, Jaap
    Barouch, Dan H.
    JOURNAL OF VIROLOGY, 2008, 82 (10) : 4844 - 4852
  • [23] Antigen-coated poly α-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations
    Lemke, Caitlin D.
    Geary, Sean M.
    Joshi, Vijaya B.
    Salem, Aliasger K.
    BIOMATERIALS, 2013, 34 (10) : 2524 - 2529
  • [24] Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
    K Banerjee
    Y Cu
    Y Sun
    K Hartog
    A Dey
    L Brito
    A Verma
    A Nandi
    P Sarkar
    NM Valiante
    AJ Geall
    SW Barnett
    GR Otten
    Retrovirology, 9
  • [25] Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
    Banerjee, K.
    Cu, Y.
    Sun, Y.
    Hartog, K.
    Dey, A.
    Brito, L.
    Verma, A.
    Nandi, A.
    Sarkar, P.
    Valiante, N. M.
    Geall, A. J.
    Barnett, S. W.
    Otten, G. R.
    RETROVIROLOGY, 2012, 9
  • [26] Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
    Thuy Trang Nguyen
    Trang Ho Thu Quach
    Thanh Mai Tran
    Huynh Ngoc Phuoc
    Ha Thi Nguyen
    Tuong Kha Vo
    Giau Van Vo
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [27] A Novel Prime-Boost Ebola Virus Vaccine Study Based on Recombinant Chimpanzee Adenovirus Vector
    Yang, Xi
    Song, Yufeng
    Wang, Xiang
    Zhang, Chao
    Zhang, Yan
    Zhou, Dongming
    MOLECULAR THERAPY, 2017, 25 (05) : 136 - 136
  • [28] Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
    Santra, Sampa
    Sun, Yue
    Korioth-Schmitz, Birgit
    Fitzgerald, Julie
    Charbonneau, Cherie
    Santos, Giannina
    Seaman, Michael S.
    Ratcliffe, Sarah J.
    Monteflori, David C.
    Nabel, Gary J.
    Ertl, Hildegund C. J.
    Letvin, Norman L.
    VACCINE, 2009, 27 (42) : 5837 - 5845
  • [29] Drug evaluation: DNA/MVA prime-boost HIV vaccine
    Kent, Stephen
    De Rose, Robert
    Rollman, Erik
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (02) : 159 - 167
  • [30] Heterologous prime-boost vaccination with a peptidebased vaccine and viral vector improves antitumor therapy
    Alfei, F.
    Belnoue, E.
    Rossi, M.
    Derouazi, M.
    Devy-Dimanche, L.
    Santiago-Raber, M. L.
    SWISS MEDICAL WEEKLY, 2023, 153 : 10S - 10S
12345